Arjantin Şirketleri tek bir sektörde faaliyet göstermektedir:sağlık teknolojisi
Bu Arjantin Şirketleri aynı sektörde, sağlık teknolojisi, faaliyet göstermektedir. En fazla ayrıntıyı almanıza yardımcı olmak için fiyat, değişim ve diğer istatistiklerle donatılmıştır. Liste her stratejiye uygun hisse senetleri içerir: ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 gibi büyük sermayeli devler, GSK PLC CEDEAR EACH REPR 1/4 ADR (USD) gibi en çok kazananlar ve daha fazlası. Listeyi filtreleyin ve şirketlerin performansını uygun bir şekilde kontrol edin.
Sembol | Piyasa Değeri | Fiyat | Değişim % | Hacim | Bağ Hacim | FKO | EPS Seyreltilmiş TTM | EPS Seyreltilmiş Büyüme TTM YY | Tmt getirisi % TTM | Analist Değerlendirmesi |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 881,88 T ARS | 16.800 ARS | −6,15% | 8,07 K | 1,40 | 79,76 | 210,62 ARS | +235,69% | 0,33% | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 881,88 T ARS | 13,90 USD | −7,33% | 446 | 1,08 | 70,81 | 210,62 ARS | +167,86% | 0,33% | — |
 JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHSDR | 446,88 T ARS | 12.450 ARS | −0,60% | 3,24 K | 0,12 | 20,84 | 597,27 ARS | +206,49% | 1,67% | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 446,88 T ARS | 1.300 ARS | 0,00% | 6 | 1,20 | — | — | — | — | — |
| DJN3DJOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 446,88 T ARS | 1,300 USD | 0,00% | 2 | 0,00 | — | — | — | — | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 446,88 T ARS | 10,40 USD | +0,97% | 191 | 0,27 | 18,68 | 597,27 ARS | +144,56% | 1,67% | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 397,44 T ARS | 22.625 ARS | −5,04% | 2,46 K | 1,89 | 10,05 | 2.251,52 ARS | +58,86% | 2,11% | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 397,44 T ARS | 19,05 USD | −4,75% | 42 | 0,60 | 9,08 | 2.251,52 ARS | +26,76% | 2,11% | — |
 ABTABBOTT LABORATORIES CEDEAR EACH 4 REP 1DR | 277,91 T ARS | 40.350 ARS | +0,37% | 191 | 0,27 | 21,22 | 1.901,66 ARS | +435,68% | 1,12% | — |
| ABTDABBOTT LABORATORIES CEDEAR EAC 4 REP 1(USD) DR | 277,91 T ARS | 33,95 USD | +4,46% | 15 | 0,68 | 19,16 | 1.901,66 ARS | +327,44% | 1,12% | — |
 AZNASTRAZENECA PLC CEDEAR EACH REP 0.5 ADR USD0.25DR | 266,35 T ARS | 42.625 ARS | −2,79% | 150 | 0,17 | 43,62 | 977,22 ARS | +146,53% | 1,60% | — |
| AZNDASTRAZENECA PLC CEDEAR EA RE 0.5 ADR (USD) DR | 266,35 T ARS | 35,75 USD | −2,72% | 37 | 1,33 | 39,25 | 977,22 ARS | +96,72% | 1,60% | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 257,34 T ARS | 33.575 ARS | −2,54% | 48 | 0,25 | 4,89 | 6.872,32 ARS | +10,89% | 3,77% | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 257,34 T ARS | 26,20 USD | −1,13% | 4 | 0,75 | 4,09 | 6.872,32 ARS | −11,51% | 3,77% | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 238,26 T ARS | 19.100 ARS | −4,86% | 3,18 K | 1,54 | 14,34 | 1.332,07 ARS | +380,66% | 2,00% | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 238,26 T ARS | 15,80 USD | −6,51% | 112 | 1,25 | 12,73 | 1.332,07 ARS | +283,54% | 2,00% | — |
 ISRGINTUITIVE SURGICAL INC CEDEAR EACH 90 REP 1 ORDDR | 228,24 T ARS | 7.150 ARS | 0,00% | 102 | 0,75 | 96,63 | 73,99 ARS | +152,31% | 0,00% | — |
 TMOTHERMO FISHER SCIENTIFIC INC CEDEAR EACH 22 REP 1DR | 184,45 T ARS | 22.500 ARS | −3,85% | 431 | 1,06 | 29,92 | 751,97 ARS | +138,83% | 0,19% | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 174,57 T ARS | 10.950 ARS | −3,10% | 699 | 0,87 | 30,80 | 355,48 ARS | +117,04% | 2,29% | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 174,57 T ARS | 8,84 USD | −4,95% | 3 | 0,04 | 26,68 | 355,48 ARS | +73,19% | 2,29% | — |
 DHRDANAHER CORP CEDEAR EACH 54 REP 1 ORDDR | 163,28 T ARS | 4.280 ARS | −3,28% | 249 | 1,57 | 45,99 | 93,05 ARS | +88,45% | 0,23% | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 156,16 T ARS | 6.930 ARS | −4,41% | 23,61 K | 0,96 | 20,36 | 340,44 ARS | +754,74% | 3,72% | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 156,16 T ARS | 5,82 USD | −4,43% | 2,12 K | 0,75 | 18,34 | 340,44 ARS | +582,03% | 3,72% | — |
| PFECPFIZER INC CEDEAR EACH 2 REP 1 ORD USD0.05 DR | 156,16 T ARS | 6,20 USD | −13,89% | 1 | 0,00 | 19,54 | 340,44 ARS | +582,03% | 3,72% | — |
 GILDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 COM USD0.001DR | 146,48 T ARS | 29.550 ARS | −5,06% | 432 | 0,63 | 25,69 | 1.150,24 ARS | — | 1,55% | — |
| GILDDGILEAD SCIENCES INC CEDEAR EACH 4 REP 1 SHS (USD) DR | 146,48 T ARS | 22,75 USD | −16,97% | 3 | 0,19 | 21,22 | 1.150,24 ARS | — | 1,55% | — |
 MDTMEDTRONIC PLC CEDEAR EACH 4 REP 1DR | 126,75 T ARS | 24.975 ARS | −1,09% | 12 | 0,04 | 31,99 | 780,62 ARS | +170,43% | 1,87% | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 116,22 T ARS | 19.200 ARS | −5,30% | 806 | 1,93 | 22,15 | 866,77 ARS | — | 3,32% | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 94,15 T ARS | 11.325 ARS | −3,82% | 1,02 K | 1,99 | 23,83 | 475,21 ARS | +66,14% | 2,86% | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 94,15 T ARS | 10,05 USD | +6,35% | 490 | 22,90 | 22,69 | 475,21 ARS | +32,57% | 2,86% | — |
 PHGKONINKLIJKE PHILIPS NV CEDEAR EACH REPR 1/5 ADRDR | 27,86 T ARS | 5.840 ARS | −6,11% | 178 | 2,03 | — | −805,76 ARS | −85,28% | 0,00% | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 20,55 T ARS | 10.900 ARS | −4,39% | 1,53 K | 2,94 | 14,76 | 738,48 ARS | +152,73% | 0,00% | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 20,55 T ARS | 9,20 USD | −6,12% | 10 | 0,55 | 13,37 | 738,48 ARS | +101,66% | 0,00% | — |
 MRNAMODERNA INC CEDEAR EACH 19 REP 1 ORDDR | 11,34 T ARS | 1.555 ARS | −12,15% | 233,2 K | 5,66 | — | −424,06 ARS | −37,78% | 0,00% | — |
| MRNADMODERNA INC CEDEAR EACH 19 REP 1 ORD (USD) DR | 11,34 T ARS | 1,330 USD | −10,14% | 4,88 K | 13,51 | — | −424,06 ARS | −9,94% | 0,00% | — |
 RICHLABORATORIOS RICHMOND SACIF | 115,88 B ARS | 1.435 ARS | −2,71% | 31,13 K | 2,29 | 5,46 | 262,78 ARS | — | 0,00% | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 3,62 B ARS | 85,0 ARS | +1,31% | 12,31 K | 2,42 | 19,91 | 4,27 ARS | +64,50% | 0,00% | — |